Annals of Clinical Epidemiology
Online ISSN : 2434-4338
Comparison of Alternative Claims-Based Operational Definitions for Cancer Control Indicators Using Nationwide Claims Data in Japan
Yoko Nakazawa, Richi Takahashi, Yasuyuki Okumura, Asao Ogawa, Norie Sawada, Yutaka Matsuoka, Manami Inoue
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 27020

Details
Abstract

Background:

Japan’s National Database of Health Insurance Claims (NDB) is used as a data source for selected national cancer control indicators. However, national policy does not explicitly define “patients with cancer” for claims-based measurement. We quantified variations in NDB-based cancer control indicator values across diagnosis-code restrictions.

Methods:

We conducted a repeated cross-sectional study using NDB data from fiscal years (FY) 2020–2022. We assessed 11 indicators using an unrestricted comparator, two all-cancer definitions requiring either any confirmed cancer diagnosis or a principal cancer diagnosis, and a six-site sensitivity analysis. Procedure counts were compared, and retained proportions were calculated relative to the unrestricted algorithm.

Results:

The algorithm requiring any confirmed cancer diagnosis retained 99.2% and 99.1% of procedure counts for cancer-specific indicators, as expected because a cancer diagnosis was required for reimbursement, and 95.1%–97.5% for cancer-predominant indicators. The principal-diagnosis definition and six-site sensitivity analysis retained 71.6%–74.6% and 61.6%–64.5%, respectively, for cancer-specific indicators. For indicators based on procedure codes not specific to cancer care, the algorithm requiring any confirmed cancer diagnosis retained 21.1%–88.4% of unrestricted procedure counts, representing the proportions that met the cancer-diagnosis restriction.

Conclusions:

NDB-based cancer control indicator values varied substantially according to the case-identification algorithm. Among the approaches examined, requiring any confirmed cancer diagnosis was selected post hoc as a reasonable default for national monitoring of these 11 indicators because it avoids reliance on principal-diagnosis coding practices and remains applicable across cancer sites. This pragmatic choice should not be interpreted as evidence of diagnostic accuracy.

Content from these authors
© 2026 Society for Clinical Epidemiology

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Next article
feedback
Top